Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$185.1 - $233.13 $30,356 - $38,233
-164 Reduced 1.91%
8,442 $1.95 Million
Q3 2023

Oct 24, 2023

SELL
$233.08 - $265.59 $4,661 - $5,311
-20 Reduced 0.23%
8,606 $2.14 Million
Q2 2023

Aug 02, 2023

BUY
$224.99 - $256.14 $144,893 - $164,954
644 Added 8.07%
8,626 $2.07 Million
Q1 2023

Apr 28, 2023

BUY
$239.75 - $277.0 $7,672 - $8,864
32 Added 0.4%
7,982 $2.01 Million
Q4 2022

Jan 31, 2023

BUY
$241.42 - $282.29 $82,082 - $95,978
340 Added 4.47%
7,950 $2.11 Million
Q3 2022

Oct 21, 2022

SELL
$247.06 - $1507.4 $1.79 Million - $10.9 Million
-7,225 Reduced 48.7%
7,610 $1.97 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $3.52 Million - $4.45 Million
14,835 New
14,835 $3.76 Million
Q4 2018

Jan 15, 2019

SELL
$94.85 - $109.54 $189,130 - $218,422
-1,994 Closed
0 $0
Q2 2018

Jul 19, 2018

SELL
$96.1 - $103.24 $376,039 - $403,978
-3,913 Reduced 66.24%
1,994 $197,000
Q1 2018

Apr 20, 2018

SELL
$92.16 - $103.8 $56,494 - $63,629
-613 Reduced 9.4%
5,907 $578,000
Q4 2017

Feb 13, 2018

SELL
$85.26 - $94.62 $30,437 - $33,779
-357 Reduced 5.19%
6,520 $605,000
Q3 2017

Oct 23, 2017

BUY
$79.29 - $88.45 $545,277 - $608,270
6,877
6,877 $590,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Prentiss Smith & CO Inc Portfolio

Follow Prentiss Smith & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.